Why the study?
Does peak cardiac power output-to-mass (CPOM) predict outcomes in patients with chronic heart failure and depressed systolic function?
Does peak cardiac power output-to-mass (CPOM) predict outcomes in patients with chronic heart failure and depressed systolic function?
Peak CPOM combined with peak VO2 provides independent and incremental prognostic value for predicting adverse outcomes in patients with chronic heart failure.
No takes yet. Share an insight, caveat, or question.
Peak CPOM may enhance risk stratification alongside VO2 in HFrEF; leaves open prospective validation before clinical adoption.
Pugliese et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: